Recursion Pharmaceuticals Inc. (RXRX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Recursion Pharmaceuticals...

    NASDAQ: RXRX · Real-Time Price · USD
    5.49
    -0.03 (-0.54%)
    At close: Oct 03, 2025, 3:59 PM
    5.46
    -0.55%
    After-hours: Oct 03, 2025, 07:58 PM EDT

    Recursion Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -463.66M -328.07M -239.48M -186.48M
    Depreciation & Amortization
    		 36.49M 24.4M 11.76M 8.4M
    Stock-Based Compensation
    		 81.69M 53.5M 27.91M 14.84M
    Other Working Capital
    		 -38.37M -49.27M 103.15M -10M
    Other Non-Cash Items
    		 -13.7M 12.64M 11.37M 4.1M
    Deferred Income Tax
    		 n/a n/a n/a 827K
    Change in Working Capital
    		 n/a -50.26M 104.92M -306K
    Operating Cash Flow
    		 -359.17M -287.78M -83.52M -158.61M
    Capital Expenditures
    		 -13.7M -11.96M -37.36M -39.8M
    Cash Acquisitions
    		 277.1M 1.84M n/a 231.95M
    Purchase of Investments
    		 n/a n/a n/a -301.14M
    Sales Maturities Of Investments
    		 n/a 480K 230.61M 69.19M
    Other Investing Acitivies
    		 -3.35M -597K 230.31M -231.95M
    Investing Cash Flow
    		 260.06M -10.23M 193.25M -271.74M
    Debt Repayment
    		 -4.44M -766K -90K -12.8M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 8.14M 12.81M 10.72M 8.44M
    Financial Cash Flow
    		 304.12M 140.13M 154.34M 458.54M
    Net Cash Flow
    		 201.6M -157.69M 263.76M 28.18M
    Free Cash Flow
    		 -372.87M -300.33M -120.88M -198.41M

    Add to Watchlist